Liu Chunyu, Li Yi, Nwosu Adaora, Ang Ting Fang Alvin, Liu Yulin, Devine Sherral, Au Rhoda, Doraiswamy P Murali
Department of Biostatistics Boston University School of Public Health Boston Massachusetts USA.
Framingham Heart Study Boston University School of Medicine Boston Massachusetts USA.
Alzheimers Dement (Amst). 2022 Nov 3;14(1):e12369. doi: 10.1002/dad2.12369. eCollection 2022.
Sex differences in Alzheimer's disease (AD) are not well understood.
We performed sex-specific analyses of AD and annualized cognitive decline with clinical and blood biomarker data in participants 60+ years old in the community-based longitudinal Framingham Heart Study Offspring Cohort ( = 1398, mean age 68 years, 55% women).
During 11 years of follow-up, women were 96% more likely than men to be diagnosed with clinical AD dementia after adjusting for age and education in the younger age group 60 to 70 years ( = 946; 95% confidence interval [CI], 1.08 to 3.56) although not in the older age group (70+) ( = 452; hazard ratio = 0.98; 95% CI, 0.68 to 1.53). Sex-differences in incident AD rates decreased with increasing levels of education. The total contribution of the biomarkers to AD risk variance was 7.6% in women and 11.7% in men. One unit (pg/ml) lower plasma Aβ42 was associated with 0.0095 unit faster memory decline in women ( = 0.0002) but not in men ( = 0.55) after adjusting for age and education.
Our study suggests that both early life and later-life pathological factors may contribute to potential sex differences in incident AD.
阿尔茨海默病(AD)中的性别差异尚未得到充分理解。
我们在基于社区的纵向弗明汉心脏研究后代队列中,对60岁及以上参与者(n = 1398,平均年龄68岁,55%为女性)的AD及年化认知衰退进行了性别特异性分析,并结合临床和血液生物标志物数据。
在11年的随访期间,在60至70岁的较年轻年龄组中,调整年龄和教育因素后,女性被诊断为临床AD痴呆的可能性比男性高96%(n = 946;95%置信区间[CI],1.08至3.56),而在70岁及以上的较年长年龄组中则不然(n = 452;风险比 = 0.98;95% CI,0.68至1.53)。AD发病率的性别差异随着教育水平的提高而减小。生物标志物对AD风险方差的总贡献率在女性中为7.6%,在男性中为11.7%。调整年龄和教育因素后,血浆Aβ42每降低1个单位(pg/ml),女性的记忆衰退速度加快0.0095个单位(p = 0.0002),而男性则不然(p = 0.55)。
我们的研究表明,早期生活和后期生活的病理因素可能都导致了AD发病率潜在的性别差异。